vs
ETHAN ALLEN INTERIORS INC（ETD）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是ETHAN ALLEN INTERIORS INC的1.5倍（$207.3M vs $135.8M），ETHAN ALLEN INTERIORS INC净利率更高（4.4% vs -62.0%，领先66.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -4.8%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -10.2%）
伊森艾伦内饰公司是美国家居家具制造商与零售商，公司注册于特拉华州，总部行政办公室位于康涅狄格州丹伯里。截至2023年6月30日，该公司年度净销售额达7.914亿美元。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ETD vs RARE — 直观对比
营收规模更大
RARE
是对方的1.5倍
$135.8M
营收增速更快
RARE
高出30.7%
-4.8%
净利率更高
ETD
高出66.4%
-62.0%
两年增速更快
RARE
近两年复合增速
-10.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $135.8M | $207.3M |
| 净利润 | $5.9M | $-128.6M |
| 毛利率 | 59.4% | — |
| 营业利润率 | 4.8% | -54.7% |
| 净利率 | 4.4% | -62.0% |
| 营收同比 | -4.8% | 25.9% |
| 净利润同比 | -38.2% | 3.5% |
| 每股收益（稀释后） | $0.23 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ETDRARE
| Q1 26 | $135.8M | — | ||
| Q4 25 | $149.9M | $207.3M | ||
| Q3 25 | $147.0M | $159.9M | ||
| Q2 25 | $160.4M | $166.5M | ||
| Q1 25 | $142.7M | $139.3M | ||
| Q4 24 | $157.3M | $164.6M | ||
| Q3 24 | $154.3M | $139.5M | ||
| Q2 24 | $168.6M | $147.0M |
净利润ETDRARE
| Q1 26 | $5.9M | — | ||
| Q4 25 | $11.7M | $-128.6M | ||
| Q3 25 | $10.5M | $-180.4M | ||
| Q2 25 | — | $-115.0M | ||
| Q1 25 | $9.6M | $-151.1M | ||
| Q4 24 | $15.0M | $-133.2M | ||
| Q3 24 | $14.7M | $-133.5M | ||
| Q2 24 | $18.5M | $-131.6M |
毛利率ETDRARE
| Q1 26 | 59.4% | — | ||
| Q4 25 | 60.9% | — | ||
| Q3 25 | 61.4% | — | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 60.8% | — |
营业利润率ETDRARE
| Q1 26 | 4.8% | — | ||
| Q4 25 | 9.5% | -54.7% | ||
| Q3 25 | 6.8% | -106.9% | ||
| Q2 25 | 9.5% | -64.8% | ||
| Q1 25 | 7.7% | -102.6% | ||
| Q4 24 | 11.5% | -74.3% | ||
| Q3 24 | 11.4% | -94.6% | ||
| Q2 24 | 13.4% | -79.1% |
净利率ETDRARE
| Q1 26 | 4.4% | — | ||
| Q4 25 | 7.8% | -62.0% | ||
| Q3 25 | 7.1% | -112.8% | ||
| Q2 25 | — | -69.0% | ||
| Q1 25 | 6.7% | -108.5% | ||
| Q4 24 | 9.5% | -80.9% | ||
| Q3 24 | 9.5% | -95.7% | ||
| Q2 24 | 11.0% | -89.5% |
每股收益（稀释后）ETDRARE
| Q1 26 | $0.23 | — | ||
| Q4 25 | $0.46 | $-1.28 | ||
| Q3 25 | $0.41 | $-1.81 | ||
| Q2 25 | $0.48 | $-1.17 | ||
| Q1 25 | $0.37 | $-1.57 | ||
| Q4 24 | $0.59 | $-1.34 | ||
| Q3 24 | $0.57 | $-1.40 | ||
| Q2 24 | $0.73 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $473.7M | $-80.0M |
| 总资产 | $723.3M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ETDRARE
| Q1 26 | $66.6M | — | ||
| Q4 25 | $139.3M | $421.0M | ||
| Q3 25 | $123.6M | $202.5M | ||
| Q2 25 | $136.1M | $176.3M | ||
| Q1 25 | $172.9M | $127.1M | ||
| Q4 24 | $139.1M | $174.0M | ||
| Q3 24 | $135.9M | $150.6M | ||
| Q2 24 | $161.0M | $480.7M |
股东权益ETDRARE
| Q1 26 | $473.7M | — | ||
| Q4 25 | $478.2M | $-80.0M | ||
| Q3 25 | $475.5M | $9.2M | ||
| Q2 25 | $482.4M | $151.3M | ||
| Q1 25 | $479.2M | $144.2M | ||
| Q4 24 | $478.8M | $255.0M | ||
| Q3 24 | $474.7M | $346.8M | ||
| Q2 24 | $483.0M | $432.4M |
总资产ETDRARE
| Q1 26 | $723.3M | — | ||
| Q4 25 | $714.8M | $1.5B | ||
| Q3 25 | $737.1M | $1.2B | ||
| Q2 25 | $737.1M | $1.3B | ||
| Q1 25 | $738.7M | $1.3B | ||
| Q4 24 | $732.6M | $1.5B | ||
| Q3 24 | $737.7M | $1.5B | ||
| Q2 24 | $744.9M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流ETDRARE
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $-99.8M | ||
| Q3 25 | $16.8M | $-91.4M | ||
| Q2 25 | $24.8M | $-108.3M | ||
| Q1 25 | $10.2M | $-166.5M | ||
| Q4 24 | $11.6M | $-79.3M | ||
| Q3 24 | $15.1M | $-67.0M | ||
| Q2 24 | $26.2M | $-77.0M |
自由现金流ETDRARE
| Q1 26 | — | — | ||
| Q4 25 | $-4.7M | $-100.8M | ||
| Q3 25 | $14.4M | $-92.7M | ||
| Q2 25 | $22.9M | $-110.7M | ||
| Q1 25 | $8.2M | $-167.8M | ||
| Q4 24 | $7.8M | $-79.5M | ||
| Q3 24 | $11.5M | $-68.6M | ||
| Q2 24 | $24.2M | $-79.0M |
自由现金流率ETDRARE
| Q1 26 | — | — | ||
| Q4 25 | -3.2% | -48.6% | ||
| Q3 25 | 9.8% | -58.0% | ||
| Q2 25 | 14.3% | -66.5% | ||
| Q1 25 | 5.7% | -120.5% | ||
| Q4 24 | 5.0% | -48.3% | ||
| Q3 24 | 7.4% | -49.2% | ||
| Q2 24 | 14.3% | -53.7% |
资本支出强度ETDRARE
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 0.5% | ||
| Q3 25 | 1.6% | 0.8% | ||
| Q2 25 | 1.2% | 1.5% | ||
| Q1 25 | 1.4% | 1.0% | ||
| Q4 24 | 2.4% | 0.1% | ||
| Q3 24 | 2.3% | 1.2% | ||
| Q2 24 | 1.2% | 1.4% |
现金转化率ETDRARE
| Q1 26 | — | — | ||
| Q4 25 | -0.16× | — | ||
| Q3 25 | 1.61× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 0.77× | — | ||
| Q3 24 | 1.02× | — | ||
| Q2 24 | 1.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ETD
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
